Analyzing...
Loading company...
Anupam Rasayan India Ltd. manufactures pharmaceutical and specialty chemical products. The company is headquartered in Surat, Gujarat. The company went IPO on 2021-03-24. The Company’s segments include Life Science Related Specialty Chemicals and Other Specialty Chemicals. The company manufactures a variety of life science related specialty chemicals comprising products related to agrochemicals, personal care, and pharmaceuticals. The firm manufactures agro intermediates and agro active ingredients for the agrochemicals industry, which are used in the manufacture of, amongst others, insecticides, fungicides, and herbicides. For the personal care industry, it provides, amongst others, anti-bacterial and ultraviolet protection intermediates, and ingredients. In the pharmaceutical segment, the Company focuses on developing intermediates and key starting materials for active pharmaceutical ingredients. The Company’s other specialty chemicals are used in diverse end-user segments, comprising specialty pigments, specialty dyes and polymer additives.
Nothing flagged for monitoring
“Operates in Chemicals — Specialty & Commodity.”
₹2,365 Cr revenue.
COGS 55.9%, employees 3.7%.
“gross block has increased from 14,000,000,000 in FY '22 to almost 24,000,000,000 in FY 2025 whereas your EBITDA is declined from 300 crores to $2.65 crores”
“operating cash flow of over $3.50 crores...on a standard basis also...it would have been over 300 crores”
“Working capital days decreased from 409 days to 247 days. Target to reduce to 200 days in near term. Net debt reduced to INR 7.30 crores.”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 5.1%▼ | 7.7% |
| ROCE | 7.5%▼ | 10.8% |
| Net Margin | 7.1%▲ | 5.1% |
| EBITDA Margin | 22.8%▲ | 11.1% |
| Debt To Equity | 0.54x▲ | 0.18x |
| Rev Growth 3yr | 14.0%▲ | 2.0% |
| EPS Growth 3yr | -3.9%▼ | -1.3% |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | ₹2,365 Cr +64.6% | ₹1,437 Cr -2.6% | ₹1,475 Cr -7.9% | ₹1,602 Cr +50.3% | ₹1,066 Cr +31.5% | ₹811 Cr |
| Other Income | ₹18 Cr +58.4% | ₹11 Cr -62.1% | ₹30 Cr +253.0% | ₹9 Cr -43.3% | ₹15 Cr -42.9% | ₹26 Cr |
| Total Income | ₹2,384 Cr +64.6% | ₹1,448 Cr -3.8% | ₹1,505 Cr -6.5% | ₹1,610 Cr +49.0% | ₹1,081 Cr +29.1% | ₹837 Cr |
| COGS | ₹1,323 Cr +118.9% | ₹604 Cr -1.6% | ₹614 Cr -12.7% | ₹704 Cr +90.2% | ₹370 Cr +9.1% | ₹339 Cr |
| ₹2,129 Cr +70.3% | ₹1,251 Cr -1.0% | ₹1,264 Cr -3.1% | ₹1,304 Cr +51.7% | ₹860 Cr +16.6% | ₹737 Cr | |
| Profit Before Tax | ₹254 Cr +28.6% | ₹198 Cr -18.2% | ₹242 Cr -21.0% | ₹306 Cr +38.4% | ₹221 Cr +121.2% | ₹100 Cr |
| ₹32 Cr -15.0% | ₹38 Cr -49.0% | ₹74 Cr -18.1% | ₹91 Cr +30.3% | ₹70 Cr +134.5% | ₹30 Cr | |
| Net Profit | ₹222 Cr +38.9% | ₹160 Cr -4.5% | ₹167 Cr -22.8% | ₹217 Cr +42.5% | ₹152 Cr +116.5% | ₹70 Cr |
| Profit (Owners) | ₹170 Cr +82.2% | ₹93 Cr -27.4% | ₹129 Cr -28.9% | ₹181 Cr +18.8% | ₹152 Cr +116.5% | ₹70 Cr |
| Minority Interest | ₹52 Cr -21.8% | ₹67 Cr +71.6% | ₹39 Cr +7.9% | ₹36 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Other Comprehensive Income | ₹7 Cr +498.5% | ₹1 Cr ↑ Recovery | (₹0.68 Cr) +59.5% | (₹2 Cr) -101.6% | (₹0.84 Cr) -12.0% | (₹0.75 Cr) |
| EPS | ₹15.06 | ₹8.49 | ₹11.71 | ₹16.83 | ₹15.18 | ₹7.04 |
| Diluted Shares | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Anupam Rasayan India Limited has informed the Exchange about submission of newspaper advertisement clippings pertaining to the Pre-Offer Advertisement and Corrigendum to the Detailed Public Statement
Anupam Rasayan India Limited has informed the Exchange about Letter of Offer regarding the open offer for acquisition of fully paid-up equity shares of Bliss GVS Pharma Limited from the Public Shareho...
Anupam Rasayan India Limited has informed the Exchange about Copy of Newspaper Publication pertaining to the Addendum to the Public Announcement, Detailed Public Statement and Draft Letter of Offer.
Anupam Rasayan India Limited has informed the Exchange about acquisition of shares
Anupam Rasayan India Limited has informed the Exchange regarding a press release dated July 15, 2026, titled "Anupam Rasayan signs Letter of Intent with BASQUEVOLT, S.A. for the potential long-term su...
Anupam Rasayan India Limited has informed the Exchange about Confirmation Certificate of Non-Applicablity of Reg. 74(5) of SEBI (DP) Regulations, 2018.
Kiran Pallavi Investments LLC has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) ...
Kiran Pallavi Investments LLC has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) ...
Anand Desai has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Anupam Rasayan India Limited has informed the Exchange about Credit Rating- Update by the credit rating agency Crisil Ratings Limited
Anupam Rasayan India Limited has informed the Exchange about Transcript
Anupam Rasayan India Limited has informed the Exchange about Copy of Newspaper Publication regarding Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended Marc...
Anupam Rasayan India Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot and e-voting results.
Anupam Rasayan India Limited has informed the Exchange regarding a press release dated February 27, 2026, titled "Anupam Rasayan completes acquisition of 100% equity stake in Jayhawk Fine Chemicals Co...
Anupam Rasayan India Limited has informed the Exchange about completion of the acquisition of Monitchem Kansas Sarl and its subsidiaries